EZH2 and prostate carcinoma: In DU145 and PC3 cells that had been depleted of MYC by siRNA-mediated knockdown, we observed reduced EZH2 promoter activity (Fig. 5B; p<0.02 for both cell lines),indicating that MYC can indeed activate EZH2 transcription in prostate cancer cell lines.